Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
Go back to Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation| EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) | Delayed: 2.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.84 | 52 Week High | $16.39 | |||
| Open | $2.84 | 52 Week Low | $13.22 | |||
| Day High | $2.84 | P/E | N/A | |||
| Day Low | $2.84 | EPS | $-1.61 | |||
| Volume | 1,018 | |||||

